Wordt geladen...
Insight into the Development of PET Radiopharmaceuticals for Oncology
While the development of positron emission tomography (PET) radiopharmaceuticals closely follows that of traditional drug development, there are several key considerations in the chemical and radiochemical synthesis, preclinical assessment, and clinical translation of PET radiotracers. As such, we o...
Bewaard in:
| Gepubliceerd in: | Cancers (Basel) |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7281377/ https://ncbi.nlm.nih.gov/pubmed/32455729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051312 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|